Free Trial

Zacks Research Has Optimistic Outlook of TriMas Q3 Earnings

TriMas logo with Industrials background

Key Points

  • Zacks Research has increased its Q3 earnings estimate for TriMas to $0.54 per share, up from a previous estimate of $0.52.
  • TriMas has a current dividend yield of 0.4% with an annualized dividend of $0.16 per share.
  • Analysts have set a target price of $45.00 for TriMas stock, reflecting positive sentiment towards the company's future performance.
  • MarketBeat previews top five stocks to own in October.

TriMas Corporation (NASDAQ:TRS - Free Report) - Zacks Research boosted their Q3 2025 EPS estimates for TriMas in a report released on Tuesday, August 12th. Zacks Research analyst M. Das now anticipates that the industrial products company will post earnings per share of $0.54 for the quarter, up from their prior forecast of $0.52. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas' FY2025 earnings at $1.95 EPS and Q4 2026 earnings at $0.38 EPS.

Other equities research analysts have also issued reports about the stock. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. KeyCorp set a $45.00 price target on shares of TriMas and gave the company an "overweight" rating in a research report on Tuesday. Finally, BWS Financial reaffirmed a "buy" rating and set a $45.00 price target (up previously from $40.00) on shares of TriMas in a report on Wednesday, July 30th.

Check Out Our Latest Report on TriMas

TriMas Stock Down 0.5%

TRS traded down $0.20 during trading on Wednesday, hitting $36.77. The company had a trading volume of 397,269 shares, compared to its average volume of 541,169. The company has a market capitalization of $1.49 billion, a PE ratio of 40.41 and a beta of 0.66. TriMas has a one year low of $19.33 and a one year high of $37.49. The firm's 50-day moving average price is $30.89 and its 200 day moving average price is $26.06. The company has a quick ratio of 1.44, a current ratio of 2.59 and a debt-to-equity ratio of 0.59.

TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.11. The firm had revenue of $274.76 million for the quarter, compared to analysts' expectations of $251.18 million. TriMas had a net margin of 3.83% and a return on equity of 11.49%. The business's revenue for the quarter was up 14.2% on a year-over-year basis. During the same period last year, the firm earned $0.43 earnings per share.

Institutional Trading of TriMas

Hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE grew its stake in TriMas by 127.3% during the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock valued at $86,400,000 after acquiring an additional 1,967,738 shares in the last quarter. Irenic Capital Management LP purchased a new position in TriMas during the first quarter valued at approximately $19,997,000. Alta Fox Capital Management LLC purchased a new position in TriMas during the first quarter valued at approximately $17,385,000. Simcoe Capital Management LLC purchased a new position in TriMas during the first quarter valued at approximately $6,451,000. Finally, Raymond James Financial Inc. purchased a new position in TriMas during the fourth quarter valued at approximately $6,698,000. Institutional investors own 99.42% of the company's stock.

Insiders Place Their Bets

In other news, Director Adrianne Shapira purchased 4,000 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were bought at an average cost of $25.82 per share, with a total value of $103,280.00. Following the completion of the transaction, the director directly owned 8,476 shares of the company's stock, valued at approximately $218,850.32. This trade represents a 89.37% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Shawn Sedaghat acquired 72,937 shares of the stock in a transaction on Thursday, May 22nd. The stock was bought at an average cost of $26.16 per share, for a total transaction of $1,908,031.92. Following the transaction, the director owned 1,883,758 shares of the company's stock, valued at approximately $49,279,109.28. This trade represents a 4.03% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 848,232 shares of company stock valued at $21,644,995 over the last 90 days. Corporate insiders own 14.20% of the company's stock.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Shareholders of record on Tuesday, August 5th were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Tuesday, August 5th. TriMas's dividend payout ratio (DPR) is presently 17.58%.

TriMas Company Profile

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Featured Articles

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.